CytomX Therapeutics, Inc.

JANE STREET GROUP, LLC CTMX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

607,218

Value ($000)

2,587

Weight

0.0%

2020 Q2 - 2025 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	2,587	0.0%	607,218	12/31/2025
2025 Q3	11/14/2025	1,280	0.0%	401,367	9/30/2025
2025 Q2	8/14/2025	27	0.0%	11,968	6/30/2025
2025 Q1	5/19/2025	13	0.0%	19,962	3/31/2025
2024 Q4	2/14/2025	22	0.0%	21,653	12/31/2024
2024 Q3	11/15/2024	32	0.0%	27,231	9/30/2024
2024 Q2	8/15/2024	97	0.0%	79,701	6/30/2024
2024 Q1	5/16/2024	401	0.0%	183,748	3/31/2024
2023 Q4	2/15/2024	45	0.0%	29,239	12/31/2023
2023 Q2	8/14/2023	33	0.0%	19,364	6/30/2023
2023 Q1	5/16/2023	61	0.0%	40,581	3/31/2023
2022 Q4	2/15/2023	66	0.0%	41,559	12/31/2022
2022 Q1	5/17/2022	54	0.0%	20,061	3/31/2022
2021 Q4	2/15/2022	81	0.0%	18,820	12/31/2021
2021 Q2	8/16/2021	536	0.0%	84,724	6/30/2021
2021 Q1	5/18/2021	134	0.0%	17,394	3/31/2021
2020 Q4	2/17/2021	101	0.0%	15,349	12/31/2020
2020 Q3	11/17/2020	127	0.0%	19,160	9/30/2020
2020 Q2	8/17/2020	134	0.0%	16,039	6/30/2020